foxo4-dri peptide senolytic 2023 2024 study Senolytics: charting a new course or enhancing existing anti-tumor therapies? | Cellular Oncology Frontiers Peptide inhibitors targeting FOXO4-p53 interactions

Name: foxo4-dri peptide senolytic 2023 2024 study Senolytics: charting a new course or enhancing existing anti-tumor therapies? | Cellular Oncology Frontiers Peptide inhibitors targeting FOXO4-p53 interactions
Brand: artnailsalamogordo.com
SKU: 73426305010
Price: 20.44 USD
Availability: InStock
Rating: 4.6291 (24 reviews)

SKU: 73426305010

4.6

USD20.44 USD68.44

Pay in 4 interest-free payments of $5.11 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness Fox 04 DRI 10 mg, Powder, Packaging Type: Box at 6500 piece in Nagpur ID: 2856500810897 Buy FOXO4 DRI Greece PharmaGrade.Store

Store: artnailsalamogordo.com · Domain: artnailsalamogordo.com

Description

The Cobas z 480 instrument (Hoffmann-La Roche Ltd., Basel, Switzerland) was used to perform the qPCR according to the following protocol: 2 min at 50 C, 10 min at 95 C, 45 cycles of 15 s at 95 C, and 1 min at 60 C